XXresearch – Uterine Fibroid Study

What: A Phase 3 study to evaluate the safety and efficacy of Elagolix in premenopausal women with heavy menstrual bleeding associated with Uterine Fibroids

Who: Females 18 – 51 years old

Duration: 18 months

Name*
First Last
Phone*
Email*
Are you a female 18 to 51 and Premenopausal?*
Have you been diagnosed with Fibroids or have symptoms of Fibroids?*
Do you experience heavy cycles every month?*
Does your cycle last longer than most women's?*